stars 1 stars 2 stars 3

DeNovX an innovative pharmaceutical company that provides platform products for pharmaceutical and medical nutrition uses. Our pharmaceutical products division is advancing the development of a treatment for ulcerative colitis. Our pharmaceutical technology division is focused on the commercialization of products to accelerate pharmaceutical development while creating new intellectual property (IP) for commercially relevant products.

DeNovX Questions

The DeNovX annual revenue was $405000 in 2026.

Andrew Bond is the Co-Founder and Chief Operations Officer of DeNovX.

3 people are employed at DeNovX.

DeNovX is based in Chicago, Illinois.

The NAICS codes for DeNovX are [32, 3254, 325, 32541].

The SIC codes for DeNovX are [28, 283].

Top DeNovX Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users